Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction'
- Posted on July 17, 2025
- By CNBC
- 2 Views
Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction'
Abbott Laboratories CEO Robert Ford unpacked his company's latest quarterly report in a Thursday interview with CNBC's Jim Cramer.
